Europe

Biopharma may have to wait for Brexit details
BioCentury
Tue, 11/13/18 - 10:09 pm
Brexit
Europe
UK
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Sat, 11/10/18 - 12:40 pm
Takeda
Shire
M&A
Europe
#WeWontRest: The benefits of giving pharma a face
Pharmaforum
Mon, 11/5/18 - 09:55 am
Europe
pharma industry
social media
Half of Clinical Trials Fail to Publish Results, UK Report Finds
RAPS.org
Tue, 10/30/18 - 07:02 pm
clinical trials
UK
Europe
transparency
Reimbursement lags cancer drug approvals, but some European countries wait longer
Biopharma Dive
Wed, 10/24/18 - 11:37 pm
Europe
drug approvals
reimbursement
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
Fierce Biotech
Sat, 10/20/18 - 11:10 pm
Europe
Novartis
ESMO
AstraZeneca
breast cancer
BYL719
Shire's drug for rare swelling disorder wins European panel green light
Reuters
Sat, 10/20/18 - 11:04 pm
EMA
Europe
Shire
Takhzyro
HAE
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
Fierce Pharma
Thu, 10/18/18 - 11:29 pm
Humira
AbbVie
Fresenius Kabi
Europe
What “no-deal” Brexit means for medical devices
Emergo
Thu, 10/18/18 - 11:22 pm
UK
Europe
Brexit
devices
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Novartis bets PRV on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Endpoints
Mon, 10/8/18 - 10:45 am
Novartis
siponimod
MS
multiple sclerosis
Europe
European biotech funding on track for record year
Fierce Biotech
Fri, 10/5/18 - 12:10 pm
Europe
biotech
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
CP Wire
Fri, 10/5/18 - 09:50 am
Bluebird Bio
transfusion-dependent anemia
LentiGlobin
EMA
Europe
Spark/Novartis eye gene therapy nears EU market – but at what price?
Pharmaforum
Sun, 09/23/18 - 10:36 pm
Spark Therapeutics
Novartis
Luxturna
gene therapy
Europe
Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again
Xconomy
Fri, 09/21/18 - 09:49 am
Europe
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
eteplirsen
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Fri, 09/21/18 - 12:06 am
Europe
biosimilars
AbbVie
Humira
Mylan
Hulio
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
JNJ
Janssen
Darzalex
daratumumab
Europe
Multiple Myeloma
Half of Europe's clinical trials fail to report results despite EU rule
Reuters
Wed, 09/12/18 - 08:16 pm
Europe
clinical trials
Merck's Keytruda clocks up new win as EU approves chemo cocktail
Yahoo/Reuters
Mon, 09/10/18 - 09:38 am
Merck
Keytruda
Europe
advanced non-squamous non-small cell lung cancer

Pages